210 related articles for article (PubMed ID: 9269784)
1. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
[TBL] [Abstract][Full Text] [Related]
3. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.
Raspadori D; Damiani D; Lenoci M; Rondelli D; Testoni N; Nardi G; Sestigiani C; Mariotti C; Birtolo S; Tozzi M; Lauria F
Leukemia; 2001 Aug; 15(8):1161-4. PubMed ID: 11480556
[TBL] [Abstract][Full Text] [Related]
4. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
[TBL] [Abstract][Full Text] [Related]
5. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
Chang H; Salma F; Yi QL; Patterson B; Brien B; Minden MD
Leuk Res; 2004 Jan; 28(1):43-8. PubMed ID: 14630079
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
9. Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?
Daniels JT; Davis BJ; Houde-McGrail L; Byrd JC
Br J Haematol; 1999 Nov; 107(2):381-3. PubMed ID: 10583228
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
Gustafson SA; Lin P; Chen SS; Chen L; Abruzzo LV; Luthra R; Medeiros LJ; Wang SA
Am J Clin Pathol; 2009 May; 131(5):647-55. PubMed ID: 19369623
[TBL] [Abstract][Full Text] [Related]
11. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
[TBL] [Abstract][Full Text] [Related]
12. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Byrd JC; Weiss RB; Arthur DC; Lawrence D; Baer MR; Davey F; Trikha ES; Carroll AJ; Tantravahi R; Qumsiyeh M; Patil SR; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 Feb; 15(2):466-75. PubMed ID: 9053467
[TBL] [Abstract][Full Text] [Related]
13. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotypic analysis of acute myeloid leukemia with t(8;21)].
Fan L; Wu YJ; Zhang JF; Qiu HR; Qiao C; Wang R; Yang H; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1410-3. PubMed ID: 21176340
[TBL] [Abstract][Full Text] [Related]
15. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival.
Rege K; Swansbury GJ; Atra AA; Horton C; Min T; Dainton MG; Matutes E; Durosinmi M; Treleaven JG; Powles RL; Catovsky D
Leuk Lymphoma; 2000 Dec; 40(1-2):67-77. PubMed ID: 11426630
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
17. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome.
Chang H; Brandwein J; Yi QL; Chun K; Patterson B; Brien B
Leuk Res; 2004 Oct; 28(10):1007-11. PubMed ID: 15289011
[TBL] [Abstract][Full Text] [Related]
18. Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.
Mrózek K; Heinonen K; Lawrence D; Carroll AJ; Koduru PR; Rao KW; Strout MP; Hutchison RE; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
Blood; 1997 Dec; 90(11):4532-8. PubMed ID: 9373264
[TBL] [Abstract][Full Text] [Related]
19. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
[TBL] [Abstract][Full Text] [Related]
20. CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22).
Jekarl DW; Kim M; Lim J; Kim Y; Han K; Lee AW; Kim HJ; Min WS
Int J Hematol; 2010 Sep; 92(2):306-13. PubMed ID: 20694842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
